Johnson Johnson JNJ Icotyde Partnership Drives Portfolio Expansion and DeRisked Biotech Upside Regeneron Pharmaceuticals REGN Unveils C5 Complement Pipeline Strategy But Execution Risks Cap NearTerm Upside APOG Apogee delivers narrow Q1 2026 earnings beat shares rise 031 percent in muted trading